Park M S, Lee E Y, Lee N S, Waniewski J, Lindholm B, Lee H B
Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea.
Perit Dial Int. 1998 Jul-Aug;18(4):402-9.
We reported anomalous transport characteristics of potassium during experimental peritoneal dialysis in rats and suggested that mechanisms of peritoneal potassium transport could be other than simple passive transport. Intracellular transport of potassium in cultured human mesothelial cells was reported to be regulated by three different pathways, such as channels blocked by ouabain, channels blocked by furosemide, and other.
To investigate the effect of ouabain on peritoneal potassium and water transport characteristics.
A single 4-hour peritoneal dwell was performed in 28 Sprague-Dawley rats. To minimize the diffusive transport of potassium, 4.5 mmol/L of KCl was added into conventional dialysis solution with 3.86% glucose [acidic peritoneal dialysis solution (APD)]. To evaluate the effect of the pH of dialysis solution on the transport of potassium and water, 4 mmol/L of NaOH was added into the potassium-containing study solutions [neutral peritoneal dialysis solution (NPD)]. To evaluate the effect of a potassium channel blocker on peritoneal potassium transport ATPase sensitive Na+-K+-transport inhibitor, ouabain (10(-5) mmol/L) was added to dialysis solutions immediately before the dwell study in eight rats with APD (APD-O) and six rats with NPD (NPD-O). Ouabain was not added in eight and six rats with APD and NPD (APD-C and NPD-C, respectively). They were used as control. Infusion volume was 30 mL. The intraperitoneal volume (V(D)) was estimated by using a volume marker dilution method with corrections for the elimination of volume marker, radioiodinated human serum albumin (RISA), from the peritoneal cavity (K(E)). The diffusive mass transport coefficient (K(BD)) and sieving coefficient (S) were estimated using the modified Babb-Randerson-Farrell model.
V(D) was significantly higher (p < 0.05 from 90 min to 240 min) and K(E) (0.027+/-0.018 mL/min for APD-O, 0.026+/-0.017 mL/min for NPD-O, and 0.030+/-0.022 mL/min for NPD-C, vs 0.058+/-0.030 mL/min for APD-C, p < 0.05 for each) significantly lower during dialysis with APD-O, NPD-O, and NPD-C than with APD-C. The intraperitoneal glucose expressed as a percentage of the initial amount was significantly higher with APD-O, NPD-C, and NPD-O than with APD-C (p < 0.05 from 90 min to 240 min). K(BD) for sodium was higher during dialysis with ouabain than without ouabain, while K(BD) for urea, glucose, and potassium, and S for urea, glucose, sodium, and potassium did not differ between the four groups.
The physiologic potassium concentration in neutral dialysis solutions and the use of ouabain decreased the intraperitoneal fluid absorption. The diffusive transport coefficient and sieving coefficient for potassium did not differ, while the diffusive transport coefficient for sodium increased during use of ouabain.
我们报道了大鼠实验性腹膜透析期间钾的异常转运特征,并提出腹膜钾转运机制可能并非简单的被动转运。据报道,培养的人腹膜间皮细胞内钾的转运受三种不同途径调节,如被哇巴因阻断的通道、被呋塞米阻断的通道以及其他途径。
研究哇巴因对腹膜钾和水转运特征的影响。
对28只Sprague-Dawley大鼠进行单次4小时的腹膜留置。为尽量减少钾的扩散转运,在含3.86%葡萄糖的传统透析液[酸性腹膜透析液(APD)]中加入4.5 mmol/L氯化钾。为评估透析液pH对钾和水转运的影响,在含钾研究溶液[中性腹膜透析液(NPD)]中加入4 mmol/L氢氧化钠。为评估钾通道阻滞剂对腹膜钾转运ATP酶敏感的钠钾转运抑制剂哇巴因(10⁻⁵ mmol/L)的影响,在8只使用APD的大鼠(APD-O)和6只使用NPD的大鼠(NPD-O)进行留置研究前,将哇巴因立即加入透析液中。8只使用APD和6只使用NPD的大鼠未加入哇巴因(分别为APD-C和NPD-C),用作对照。输注体积为30 mL。采用体积标记物稀释法并校正腹膜腔内放射性碘化人血清白蛋白(RISA)体积标记物的消除来估计腹膜内体积(V(D))。使用改良的Babb-Randerson-Farrell模型估计扩散质量转运系数(K(BD))和筛系数(S)。
与APD-C相比,APD-O、NPD-O和NPD-C透析期间V(D)显著更高(90分钟至240分钟时p < 0.05),K(E)显著更低(APD-O为0.027±0.018 mL/分钟,NPD-O为0.026±0.017 mL/分钟,NPD-C为0.030±0.022 mL/分钟,而APD-C为0.058±0.030 mL/分钟,每组p < 0.05)。以初始量的百分比表示的腹膜内葡萄糖,APD-O、NPD-C和NPD-O比APD-C显著更高(90分钟至240分钟时p < 0.05)。使用哇巴因透析期间钠的K(BD)高于未使用哇巴因时,而四组之间尿素、葡萄糖和钾的K(BD)以及尿素、葡萄糖、钠和钾的S没有差异。
中性透析液中的生理钾浓度以及哇巴因的使用降低了腹膜内液体吸收。钾的扩散转运系数和筛系数没有差异,而使用哇巴因期间钠的扩散转运系数增加。